› Forums › General Melanoma Community › MK-1454 Clinical Trial
- This topic has 6 replies, 4 voices, and was last updated 5 years, 3 months ago by
sks2019.
- Post
-
- January 31, 2020 at 6:06 pm
Mom has been presented with another clinical trial option for her 7cm liver tumor. Its a phase 1 trial with a combination of drug MK-1454 with Keytruda. MK-1454 is injected directly into the liver tumor for 6 weeks once a week , Keytruda once every 3 weeks.I am concerned as this a phase 1 trial and its basically her getting a liver biopsy every week. Any thoughts Bubbles and Ed ?
https://clinicaltrials.ucsf.edu/trial/NCT03010176
Thanks
- Replies
-
-
- January 31, 2020 at 7:06 pm
Here are a couple of articles about Mk-1454, which is another injectable and in this case it is trying to target the ‘Sting” pathway. At the 12:33 min mark of the following video that features Dr. Omid Hamid he gets into injectables and he talks a little about the sting pathway. T-vec + ipi has been studied over the last few years as well as t-vec plus pembro and I thing nivo, TLR-9 agoinst are being investigated and there are a few more trials of different agent mainly for melanoma resistant patients to immunotherapy. To the best of my knowledge other than T-vec none have been approved yet but many of them show promise!!! I will give you a couple of article on MK-1454 that I came across and from what I have found it seems only a small # of patients have tried this drug and I am not sure if any melanoma patients have tried. T-vec on the other hand is a little future down the road when it comes to actual melanoma patients and actual results in melanoma patients. Best Wishes!!!Ed https://investors.merck.com/news/press-release-details/2018/First-Presentation-of-Early-Data-for-Mercks-Investigational-STING-Agonist-MK-1454-in-Patients-with-Advanced-Solid-Tumors-or-Lymphomas-at-ESMO-2018-Congress/default.aspx https://dailynews.ascopubs.org/do/10.1200/ADN.19.190427/full/-
- January 31, 2020 at 7:07 pm
Here is the video and it starts around 9:30 min mark on injectable and specific to sting pathway at 12:33 min mark. https://www.youtube.com/watch?v=fbSHUEbhTho&feature=youtu.be -
- January 31, 2020 at 7:13 pm
Here is another video that features T-vec and Dr. Andtbacka from Huntsman hospital, Utah. https://www.youtube.com/watch?time_continue=8&v=rIsJOfW4gLM&feature=emb_logo
-
- January 31, 2020 at 9:33 pm
Ed has given you good information – as ever. Here are some additional articles on intralesional therapy: https://chaoticallypreciselifeloveandmelanoma.blogspot.com/search?q=intralesional&max-results=20&by-date=trueAs far as picking the trial I would participate in if I were in your mom’s shoes????
I would have the doc give me a specific list of the trials for which she is considered eligible and have him give me a play by play of the pros and cons of each. Additional important information to my mind is speed of entry. Melanoma makes the most of time it has untreated and some trials required certain lengths of “wash out” periods or just ‘x’ amount of time to get enrolled.
Yours, celeste
-
- February 2, 2020 at 2:51 am
I agree with Celeste about requesting specific pros and cons from your oncologist regarding each trial your mom is eligible for, as well as how quickly she can start. I would not be concerned about having weekly liver biopsies since it is not a very invasive procedure. I had 4 liver tumors, the largest also being 7 cm and my melanoma was diagnosed following a liver biopsy. I had minimal pain afterward and was home the same day after 4-5 hrs in the hospital only as an inpatient. Compared to the immunotherapy and targeted treatment side-effects, the actual liver biopsy is absolutely nothing to be worried about. Hopefully, the liver tumor shrinks enough so that it becomes surgically resectable. Also, once the tumor burden is reduced, maybe another type of therapy is more effective.
Best of luck, -
- February 4, 2020 at 12:22 am
Thanks ED, Bubbles and MelMel. Cant thank enough for the help you provide.
Ed, I am not that good at reading medical articles but get the idea of what you were mentioning.
I discussed the option of TVec + ipi with the doc and he said thats only for cutaneous lesions and not liver. I today researched on the fb group for mucosal melanoma and see there are folks who recieved tvec into liver lesions and have benefitted. Not sure why Dr.Daud was not in favor of that.for MK-1454 the last published results shows 0% CR ( complete response ) and 25% partial response. SO i am really confused.
Being at UC i feel i am always steered towards phase 1 trials instead of treatments that are FDA approved.
Also based on my research TIL is also close to being FDA approved ( I know its never 100% unless its approved ) , would be my last approach considering the side effects.
Until we hear back from the drug company , Mom will be going for radiation mapping to see if she can get the targeted liver radioEmbolization which I feel is an easier process
-
- You must be logged in to reply to this topic.